Discover
ERNA
Ernexa Therapeutics Inc.
6.70
2 x 5.25
2 x 8.44
bid
ask
+
0.05
0.82%
2 @ 04:00 PM
6.72 +0.02 (0.24%)
| Ytd | -77.65% | |
| 1y | -85.27% |
6.50
day range
7.28
3.18
52 week range
71.50
| Open | 6.62 | Prev Close | 6.65 | Low | 6.50 | High | 7.28 | Mkt Cap | 7.82M |
| Vol | 96.88K | Avg Vol | 1.65M | EPS | 1214.25 | P/E | 0.01 | Forward P/E | -0.03 |
| Beta | 7.77 | Short Ratio | 1.07 | Inst. Own | 11.00% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 7.62 | 200-d Avg | 19.79 | 1yr Est | 3.00 |
ERNA News
globenewswire.com
Ernexa Therapeutics Launches CEO Corner to Provide Deeper Insights into Company Progress, Scientific
New platform provides additional perspective on Ernexa's mission to deliver hope for patients throug
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
Ernexa Therapeutics Advances ERNA-101 Toward IND Filing In Q3 2026; Targeting Phase 1 Cancer Trial I
Ernexa Therapeutics (NASDAQ:ERNA), an industry innovator developing novel cell therapies for the tre